(HealthDay News) — The long-term effects of fee-for-service (FFS)-based reimbursement cuts on processes and outcomes of care for stroke may be mixed, according to research published online December 9 in Circulation: Cardiovascular Quality and Outcomes.
Yu-Chi Tung, PhD, of National Taiwan University in Taipei, and colleagues performed an interrupted time-series study using data for 411,487 patients with stroke admitted to general acute care hospitals in Taiwan from 1997–2010. The long-term effects of FFS-based reimbursement cuts on trends in processes and outcomes of care for stroke were examined.
After adjustments for secular trends and other confounding variables, the researchers found that the implementation of FFS-based reimbursement cuts was associated with increasing trend changes in computed tomography scanning/magnetic resonance imaging (0.31% per quarter; P=0.013), physical therapy/occupational therapy assessment (0.25% per quarter; P<0.001), and statin use (0.18% per quarter; P=0.027). However, the cuts were also associated with negative effects on antiplatelet/anticoagulant use (−0.20% per quarter; P<0.001) and 30-day mortality (0.065 per quarter; P<0.001).
“In other words, the FFS-based reimbursement cuts may ensurethe provision of profitable services to patients, but the reimbursementcuts may place pressure on hospitals to reduce unprofitable services or levels of nurse staffing, which arein turn associated with mortality,” the authors write. “It is imperative that wereduce costs and improve value, but at the same time we need to pay more attention to identifying unexpected effects that are associated with slow improvements in outcomes of stroke care.”